Free Trial
NASDAQ:BRBI

BR Biopharma Q2 2026 Earnings Results & Report

BR Biopharma logo
$15.20 -0.14 (-0.92%)
Closing price 10/12/2026 03:41 PM Eastern
Extended Trading
$14.90 -0.30 (-1.97%)
As of 10/12/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BR Biopharma reported Q2 2026 earnings on June 30, 2026. The company reported EPS of $0.09, while revenue was $25.13 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens

BR Biopharma EPS Results

Actual EPS
$0.09
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BR Biopharma Revenue Results

Actual Revenue
$25.13 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

BR Biopharma Q2 2026 Earnings FAQ

BR Biopharma (NASDAQ:BRBI) reported earnings of $0.09 per share for Q2 2026. The report was announced on Tuesday, June 30, 2026.

BR Biopharma reported revenue of $25.13 million for Q2 2026.

BR Biopharma Earnings Headlines

No headlines for this company have been tracked by MarketBeat.com
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BR Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BR Biopharma and other key companies, straight to your email.

About BR Biopharma

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.

View BR Biopharma Profile